Welcome to the new Dermasphere site!
Jan. 8, 2024

122. Dr. Feldman on THE DECOY EFFECT - Antihistamines worsen ACD - Isocyanates and AD - Roflumilast for SD - Probiotic trial for AD

122. Dr. Feldman on THE DECOY EFFECT - Antihistamines worsen ACD - Isocyanates and AD - Roflumilast for SD - Probiotic trial for AD

Dr. Feldman on THE DECOY EFFECT [Dr. Feldman's Book]

Antihistamines worsen ACD [article]

Isocyanates and AD [article]

Roflumilast for SD [article]

Probiotic trial for AD [article]

Want to donate to the cause? Do so here! http://www.uofuhealth.org/dermasphere

Check out our video content on YouTube: https://www.youtube.com/@dermaspherepodcast

and VuMedi!: https://www.vumedi.com/channel/dermasphere/

The University of Utah's Dermatology ECHO: ⁠⁠https://physicians.utah.edu/echo/dermatology-primarycare -

⁠⁠Connect with us!

- Web: ⁠https://dermaspherepodcast.com/⁠

- Twitter: @DermaspherePC

- Instagram: dermaspherepodcast

- Facebook: https://www.facebook.com/DermaspherePodcast/

- Check out Luke and Michelle’s other podcast, SkinCast! ⁠https://healthcare.utah.edu/dermatology/skincast/⁠

Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:

- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)

- ⁠https://www.levelex.com/games/top-derm⁠ (A free dermatology game to learn more dermatology!)

Dr. Steven Feldman MD, PhD Profile Photo

Dr. Feldman is a board-certified dermatologist and dermatopathologist who practices general medical dermatology (with little surgery or cosmetic dermatology) and specializes in psoriasis treatment. He is on the Medical Board of the National Psoriasis Foundation and, in 2019, received the Foundation’s Outstanding Educator in Psoriatic Disease award.